← Back to Clinical Trials
Recruiting NCT07025070

NCT07025070 The Link Between Physical Activity and Brain Health in Healthy Adults

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07025070
Status Recruiting
Phase
Sponsor Technical University of Madrid
Condition Alzheimer Disease
Study Type OBSERVATIONAL
Enrollment 60 participants
Start Date 2024-11-25
Primary Completion 2026-01

Trial Parameters

Condition Alzheimer Disease
Sponsor Technical University of Madrid
Study Type OBSERVATIONAL
Phase N/A
Enrollment 60
Sex ALL
Min Age 40 Years
Max Age 75 Years
Start Date 2024-11-25
Completion 2026-01

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this observational study is to investigate the cross-sectional relationship between physical activity and brain health from a multiscale approach (neuropsychology, neuroimaging, peripheral biomarkers and genetics) in former athletes and sedentary individuals. The main question it aims to answer is: Do former athletes have better brain structure than sedentary people? Evaluating the differences in neurodegenerative processes between competitive training and sedentary and inactivity.

Eligibility Criteria

Inclusion Criteria: * Group A: ex-athletes and continue to perform regular physical exercise (minimum 3 days/week of moderate-vigorous intensity). * Group B: sedentary individuals, (i.e., perform \<150 min of moderate intensity exercise per week or IPAQ score\<600 MET min/week). * In both groups (A and B) the conditions of physical exercise or sedentary lifestyle must have been maintained for at least 6 months prior to the evaluations. * Not having a history of neurological or psychiatric disorder or suffering from a serious medical condition Exclusion Criteria: * Medical conditions that have a high risk of associated cognitive symptoms. * Severe head injury with loss of consciousness within the previous 5 years. * Alcoholism (\>3 alcoholic drinks per day). * Chronic use of anxiolytics, neuroleptics, narcotics, anticonvulsants, or sedative hypnotics. * Hearing or visual impairment that would preclude testing * History of neurological disease with clinically relevant impact on cognition

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology